{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:27Z","timestamp":1790959167613,"version":"4.1.0"},"reference-count":179,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Melatonin is a ubiquitous molecule found in living organisms, ranging from bacteria to plants and mammals. It possesses various properties, partly due to its robust antioxidant nature and partly owed to its specific interaction with melatonin receptors present in almost all tissues. Melatonin regulates different physiological functions and contributes to the homeostasis of the entire organism. In the human eye, a small amount of melatonin is also present, produced by cells in the anterior segment and the posterior pole, including the retina. In the eye, melatonin may provide antioxidant protection along with regulating physiological functions of ocular tissues, including intraocular pressure (IOP). Therefore, it is conceivable that the exogenous topical administration of sufficiently high amounts of melatonin to the eye could be beneficial in several instances: for the treatment of eye pathologies like glaucoma, due to the IOP-lowering and neuroprotection effects of melatonin; for the prevention of other dysfunctions, such as dry eye and refractive defects (cataract and myopia) mainly due to its antioxidant properties; for diabetic retinopathy due to its metabolic influence and neuroprotective effects; for macular degeneration due to the antioxidant and neuroprotective properties; and for uveitis, mostly owing to anti-inflammatory and immunomodulatory properties. This paper reviews the scientific evidence supporting the use of melatonin in different ocular districts. Moreover, it provides data suggesting that the topical administration of melatonin as eye drops is a real possibility, utilizing nanotechnological formulations that could improve its solubility and permeation through the eye. This way, its distribution and concentration in different ocular tissues may support its pleiotropic therapeutic effects.<\/jats:p>","DOI":"10.3390\/ph17040441","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T06:33:16Z","timestamp":1711693996000},"page":"441","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The Therapeutic Trip of Melatonin Eye Drops: From the Ocular Surface to the Retina"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9577-2585","authenticated-orcid":false,"given":"Dario","family":"Rusciano","sequence":"first","affiliation":[{"name":"Fidia Research Centre, c\/o University of Catania, Via Santa Sofia 89, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia 89, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/S0021-9258(18)69351-2","article-title":"Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands","volume":"235","author":"Lerner","year":"1960","journal-title":"J. Biol. Chem."},{"key":"ref_2","first-page":"289","article-title":"Melatonin: Fifty years of scientific journey from the discovery in bovine pineal gland to delineation of functions in human","volume":"45","author":"Chowdhury","year":"2008","journal-title":"Indian J. Biochem. Biophys."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Taverne, Y.J., Merkus, D., Bogers, A.J., Halliwell, B., Duncker, D.J., and Lyons, T.W. (2018). Reactive Oxygen Species: Radical Factors in the Evolution of Animal Life: A molecular timescale from Earth\u2019s earliest history to the rise of complex life. Bioessays, 40.","DOI":"10.1002\/bies.201700158"},{"key":"ref_4","unstructured":"Davies, K.J.A., and Ursini, F. (1995). The Oxygen Paradox, Cleup University Press."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fendo.2019.00249","article-title":"Melatonin Synthesis and Function: Evolutionary History in Animals and Plants","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"15858","DOI":"10.3390\/ijms150915858","article-title":"Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: Relation to their biological functions","volume":"15","author":"Tan","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/jpi.12026","article-title":"Mitochondria and chloroplasts as the original sites of melatonin synthesis: A hypothesis related to melatonin\u2019s primary function and evolution in eukaryotes","volume":"54","author":"Tan","year":"2013","journal-title":"J. Pineal Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Tan, D.X., Manchester, L.C., Qin, L., and Reiter, R.J. (2016). Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17122124"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jpi.12010","article-title":"On the free radical scavenging activities of melatonin\u2019s metabolites, AFMK and AMK","volume":"54","author":"Galano","year":"2013","journal-title":"J. Pineal Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/09291016.2016.1268330","article-title":"Dexamethasone Modulates Melatonin MT2 Receptor Expression in Splenic Tissue and Humoral Immune Response in Mice Biol","volume":"48","author":"Singh","year":"2017","journal-title":"Rhythm. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e00539","DOI":"10.1002\/prp2.539","article-title":"Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT1 and MT2 receptors","volume":"8","author":"Legros","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/biof.23","article-title":"Melatonin: Signaling mechanisms of a pleiotropic agent","volume":"35","author":"Hardeland","year":"2009","journal-title":"Biofactors"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pneurobio.2008.04.001","article-title":"Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways","volume":"85","author":"Trakht","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.2174\/1381612825666191113110225","article-title":"Melatonin: Implications for Ocular Disease and Therapeutic Potential","volume":"25","author":"Scuderi","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.pharmthera.2006.11.003","article-title":"Melatonin receptors in the eye: Location, second messengers and role in ocular physiology","volume":"113","author":"Pintor","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0731-7085(00)00259-4","article-title":"Photostability of drugs: Photodegradation of melatonin and its determination in commercial formulations","volume":"23","author":"Andrisano","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpha.2017.04.001","article-title":"Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial","volume":"7","author":"Filali","year":"2017","journal-title":"J. Pharm. Anal."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cantarini, M., Rusciano, D., Amato, R., Canovai, A., Cammalleri, M., Monte, M.D., Minnelli, C., Laudadio, E., Mobbili, G., and Giorgini, G. (2023). Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors hMT1 and hMT2. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032863"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"721869","DOI":"10.3389\/fphar.2021.721869","article-title":"Therapeutic Effects of Melatonin on Ocular Diseases: Knowledge Map and Perspective","volume":"12","author":"Yu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1600-079X.1995.tb00145.x","article-title":"Stability of melatonin in aqueous solution","volume":"18","author":"Cavallo","year":"1995","journal-title":"J. Pineal Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1034\/j.1600-079x.2001.310209.x","article-title":"The effect of variations in pH and temperature on stability of melatonin in aqueous solution","volume":"31","author":"Daya","year":"2001","journal-title":"J. Pineal Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Vlachou, M., and Siamidi, A. (2018). Melatonin Modified Release Formulations Designed for Sleep Disorders [Internet]. Melatonin\u2014Molecular Biology, Clinical and Pharmaceutical Approaches, IntechOpen.","DOI":"10.5772\/intechopen.78337"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/08982100802465941","article-title":"Nanoliposomes and their applications in food nanotechnology","volume":"18","author":"Mozafari","year":"2008","journal-title":"J. Liposome Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Quinteros, D., Vicario-de-la-Torre, M., Andr\u00e9s-Guerrero, V., Palma, S., Allemandi, D., Herrero-Vanrell, R., and Molina-Mart\u00ednez, I.T. (2014). Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0110344"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100798","DOI":"10.1016\/j.preteyeres.2019.100798","article-title":"Melatonin and the control of intraocular pressure","volume":"75","author":"Alkozi","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_26","first-page":"61","article-title":"Application of nanoparticles in ocular drug delivery systems","volume":"1","year":"2020","journal-title":"Health Technol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"990505","DOI":"10.3389\/fphar.2022.990505","article-title":"Drug-loaded PEG-PLGA nanoparticles for cancer treatment","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105304","DOI":"10.1016\/j.chemphyslip.2023.105304","article-title":"Polymeric nanoparticles containing babassu oil: A proposed drug delivery system for controlled release of hydrophilic compounds","volume":"253","author":"Silveira","year":"2023","journal-title":"Chem. Phys. Lipids"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"108222","DOI":"10.1016\/j.exer.2020.108222","article-title":"Neuroprotective effect of melatonin loaded in ethylcellulose nanoparticles applied topically in a retinal degeneration model in rabbits","volume":"200","author":"Bessone","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.colsurfb.2016.02.002","article-title":"Innovative hybrid vs polymeric nanocapsules: The influence of the cationic lipid coating on the \u201c4S\u201d","volume":"141","author":"Carbone","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2017.01.012","article-title":"Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies","volume":"248","author":"Mandal","year":"2017","journal-title":"J. Control Release"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s13346-022-01182-x","article-title":"Soluplus\u00ae polymeric nanomicelles improve solubility of BCS-class II drugs","volume":"12","author":"Pignatello","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Dal Monte, M., Cammalleri, M., Amato, R., Pezzino, S., Corsaro, R., Bagnoli, P., and Rusciano, D. (2020). A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239267"},{"key":"ref_34","first-page":"733","article-title":"Commentary: Amphiphiles and their aggregates in basic and applied science. A post-conference thought on nomenclature","volume":"10","author":"Mozafari","year":"2005","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Souto, E.B., Dias-Ferreira, J., L\u00f3pez-Machado, A., Ettcheto, M., Cano, A., Camins Espuny, A., Espina, M., Garcia, M.L., and S\u00e1nchez-L\u00f3pez, E. (2019). Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11090460"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Chu, M. (2017). The World Scientific Encyclopedia of Nanomedicine and Bioengineering II: Bioimplants, Regenerative Medicine, and Nano-Cancer Diagnosis and Phototherapy Volume 2: Advanced Nanomaterials for Bioimaging and Cancer Therapy, World Scientific Publishing.","DOI":"10.1142\/9559-vol2"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.112.202036","article-title":"Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: Significance for combination therapy in glaucoma","volume":"346","author":"Crooke","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2147\/IJN.S403337","article-title":"Suppression of NLRP3\/Caspase-1\/GSDMD Mediated Corneal Epithelium Pyroptosis Using Melatonin-Loaded Liposomes to Inhibit Benzalkonium Chloride-Induced Dry Eye Disease","volume":"18","author":"Lou","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_39","first-page":"8045","article-title":"Nanostructured Lipid Carriers Based Drug Delivery System: A Review","volume":"7","author":"Mrudula","year":"2017","journal-title":"Indo Am. J. Pharm. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijpharm.2014.11.032","article-title":"Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit","volume":"478","author":"Leonardi","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2012.10.014","article-title":"Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits","volume":"440","author":"Musumeci","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska, A., Carreir\u00f3, F., Oliveira, A.M., Neves, A., Pires, B., Venkatesh, D.N., Durazzo, A., Lucarini, M., Eder, P., and Silva, A.M. (2020). Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Molecules, 25.","DOI":"10.3390\/molecules25163731"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e12828","DOI":"10.1111\/jpi.12828","article-title":"Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model","volume":"73","author":"Ye","year":"2022","journal-title":"J. Pineal Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Dal Monte, M., Cammalleri, M., Pezzino, S., Corsaro, R., Pescosolido, N., Bagnoli, P., and Rusciano, D. (2020). Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy. Diagnostics, 10.","DOI":"10.3390\/diagnostics10030138"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejps.2015.04.003","article-title":"Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model","volume":"75","author":"Hafner","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zingale, E., Bonaccorso, A., D\u2019Amico, A.G., Lombardo, R., D\u2019Agata, V., Rautio, J., and Pignatello, R. (2024). Formulating Resveratrol and Melatonin Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Ocular Administration Using Design of Experiments. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16010125"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Romeo, A., Kazsoki, A., Omer, S., Pinke, B., M\u00e9sz\u00e1ros, L., Musumeci, T., and Zelk\u00f3, R. (2023). Formulation and Characterization of Electrospun Nanofibers for Melatonin Ocular Delivery. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15041296"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Serramito, M., Pereira-da-Mota, A.F., Carpena-Torres, C., Huete-Toral, F., Alvarez-Lorenzo, C., and Carracedo, G. (2022). Melatonin-Eluting Contact Lenses Effect on Tear Volume: In Vitro and In Vivo Experiments. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14051019"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Navarro-Gil, F.J., Huete-Toral, F., Dom\u00ednguez-God\u00ednez, C.O., Carracedo, G., and Crooke, A. (2022). Contact Lenses Loaded with Melatonin Analogs: A Promising Therapeutic Tool against Dry Eye Disease. J. Clin. Med., 11.","DOI":"10.3390\/jcm11123483"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop","volume":"5","author":"Lemp","year":"2007","journal-title":"Ocul. Surf."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jtos.2016.09.003","article-title":"New Perspectives on Dry Eye Definition and Diagnosis: A Consensus Report by the Asia Dry Eye Society","volume":"15","author":"Tsubota","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jphotobiol.2003.07.004","article-title":"Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure","volume":"71","author":"Ciuffi","year":"2003","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"108491","DOI":"10.1016\/j.exer.2021.108491","article-title":"Melatonin ameliorates oxidative stress-mediated injuries through induction of HO-1 and restores autophagic flux in dry eye","volume":"205","author":"Wang","year":"2021","journal-title":"Exp. Eye Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.21037\/atm-21-4927","article-title":"Melatonin exerts anti-angiogenic and anti-inflammatory effects in alkali-burned corneas","volume":"10","author":"Meng","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"778892","DOI":"10.3389\/fphar.2021.778892","article-title":"Treatment with Melatonin After Corneal Graft Attenuates Rejection","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1530\/JOE-16-0117","article-title":"Potential benefits of melatonin in organ transplantation: A review","volume":"229","author":"Tan","year":"2016","journal-title":"J. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.optom.2016.03.002","article-title":"Presence of melatonin in human tears","volume":"10","author":"Carracedo","year":"2017","journal-title":"J. Optom."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/02713683.2014.914540","article-title":"Effect of melatonin and analogues on corneal wound healing: Involvement of Mt2 melatonin receptor","volume":"40","author":"Crooke","year":"2015","journal-title":"Curr. Eye Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1124\/jpet.119.259192","article-title":"Effect of Melatonin and Its Analogs on Tear Secretion","volume":"371","author":"Crooke","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/17460441.2018.1419184","article-title":"Docking studies for melatonin receptors","volume":"13","author":"Alkozi","year":"2018","journal-title":"Expert. Opin. Drug Discov."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2006.09.012","article-title":"Melatonin potentiates tear secretion induced by diadenosine tetraphosphate in the rabbit","volume":"552","author":"Hoyle","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/02713683.2021.2022163","article-title":"Copolymer Micelle-administered Melatonin Ameliorates Hyperosmolarity-induced Ocular Surface Damage through Regulating PINK1-mediated Mitophagy","volume":"47","author":"Xu","year":"2022","journal-title":"Curr. Eye Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/S0042-6989(03)00428-0","article-title":"Changes in the internal structure of the human crystalline lens with age and accommodation","volume":"43","author":"Dubbelman","year":"2003","journal-title":"Vision. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"ORSF54-9","DOI":"10.1167\/iovs.13-12940","article-title":"Aging and age-related diseases of the ocular lens and vitreous body","volume":"54","author":"Petrash","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/exer.2001.1111","article-title":"Lens organelle degradation","volume":"74","author":"Bassnett","year":"2002","journal-title":"Exp. Eye Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molmed.2012.03.005","article-title":"Protein misfolding and aggregation in cataract disease and prospects for prevention","volume":"18","author":"Moreau","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_68","first-page":"1911","article-title":"Cataract as a protein condensation disease: The Proctor Lecture","volume":"38","author":"Benedek","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3109\/02713689208999548","article-title":"Mitochondrial dynamics in differentiating fiber cells of the mammalian lens","volume":"11","author":"Bassnett","year":"1992","journal-title":"Curr. Eye Res."},{"key":"ref_70","first-page":"1793","article-title":"The fate of the Golgi apparatus and the endoplasmic reticulum during lens fiber cell differentiation","volume":"36","author":"Bassnett","year":"1995","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1167\/iovs.05-0808","article-title":"Accumulation of DNA, nuclear and mitochondrial debris, and ROS at sites of age-related cortical cataract in mice","volume":"46","author":"Pendergrass","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0006-8993(74)90938-X","article-title":"Immunohistological localization of N-acetylindolealkylamines in pineal gland, retina and cerebellum","volume":"81","author":"Bubenik","year":"1974","journal-title":"Brain Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/jop.1985.1.149","article-title":"N-acetyltransferase activity and melatonin level in the eyes of glaucomatous chickens","volume":"1","author":"Aimoto","year":"1985","journal-title":"J. Ocul. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-079X.1984.tb00190.x","article-title":"Increases in volume, fluid content, and lens weight of eyes following systemic administration of melatonin","volume":"1","author":"Quay","year":"1984","journal-title":"J. Pineal Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1006\/exer.2000.0845","article-title":"Circadian rhythm of serotonin N -acetyltransferase activity in rat lens","volume":"70","author":"Abe","year":"2000","journal-title":"Exp. Eye Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0006-291X(88)81353-6","article-title":"Melatonin in the lacrimal gland: First demonstration and experimental manipulation","volume":"153","author":"Mhatre","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-079X.1994.tb00119.x","article-title":"Inhibitory effect of melatonin on cataract formation in newborn rats: Evidence for an antioxidative role for melatonin","volume":"17","author":"Abe","year":"1994","journal-title":"J. Pineal Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/02713680600899663","article-title":"Use of melatonin to prevent selenite-induced cataract formation in rat eyes","volume":"31","author":"Aydin","year":"2006","journal-title":"Curr. Eye Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/10715762.2013.808743","article-title":"The role of melatonin as an antioxidant in human lens epithelial cells","volume":"47","author":"Bai","year":"2013","journal-title":"Free Radic. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.exer.2013.08.017","article-title":"Autophagy and mitophagy participate in ocular lens organelle degradation","volume":"116","author":"Costello","year":"2013","journal-title":"Exp. Eye Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"16848","DOI":"10.3390\/ijms150916848","article-title":"Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways","volume":"15","author":"Jenwitheesuk","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Mi, Y., Wei, C., Sun, L., Liu, H., Zhang, J., Luo, J., Yu, X., He, J., Ge, H., and Liu, P. (2023). Melatonin inhibits ferroptosis and delays age-related cataract by regulating SIRT6\/p-Nrf2\/GPX4 and SIRT6\/NCOA4\/FTH1 pathways. Biomed. Pharmacother., 157.","DOI":"10.1016\/j.biopha.2022.114048"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"108912","DOI":"10.1016\/j.exer.2021.108912","article-title":"Melatonin counteracts oxidative damage in lens by regulation of Nrf2 and NLRP3 inflammasome activity","volume":"215","author":"Alkozi","year":"2022","journal-title":"Exp. Eye Res."},{"key":"ref_84","first-page":"2","article-title":"Protective effects of melatonin as an eye drops against selenite-induced cataract in rat pups","volume":"17","author":"Ohannes","year":"2009","journal-title":"Saudi Pharm. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.exer.2012.08.009","article-title":"Melatonin: An underappreciated player in retinal physiology and pathophysiology","volume":"103","author":"Tosini","year":"2012","journal-title":"Exp. Eye Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/bies.20777","article-title":"The circadian clock system in the mammalian retina","volume":"30","author":"Tosini","year":"2008","journal-title":"Bioessays"},{"key":"ref_87","first-page":"889","article-title":"MT(1) melatonin receptor in the human retina: Expression and localization","volume":"43","author":"Scher","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/bjp.2008.184","article-title":"Melatonin receptors, heterodimerization, signal transduction and binding sites: What\u2019s new?","volume":"154","author":"Jockers","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1073\/pnas.0904400106","article-title":"Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptor","volume":"106","author":"Baba","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/pr.110.002832","article-title":"International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors","volume":"62","author":"Dubocovich","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-079X.1999.tb00582.x","article-title":"Melatonin as an antioxidant in retinal photoreceptors","volume":"26","author":"Marchiafava","year":"1999","journal-title":"J. Pineal Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.exer.2018.07.026","article-title":"Heteromeric MT1\/MT2 melatonin receptors modulate the scotopic electroretinogram via PKC\u03b6 in mice","volume":"177","author":"Piano","year":"2018","journal-title":"Exp. Eye Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/BF01923951","article-title":"Melatonin decreases the amplitude of the b-wave of the human electroretinogram","volume":"49","author":"Emser","year":"1993","journal-title":"Experientia"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-079X.2004.00195.x","article-title":"Melatonin regulates circadian electroretinogram rhythms in a dose- and time-dependent fashion","volume":"38","author":"Peters","year":"2005","journal-title":"J. Pineal Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fphar.2018.01280","article-title":"Oxidative Stress in Age-Related Macular Degeneration: Nrf2 as Therapeutic Target","volume":"9","author":"Bellezza","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_97","first-page":"1673","article-title":"Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients","volume":"21","author":"Rosen","year":"2009","journal-title":"Mol. Vis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1196\/annals.1356.029","article-title":"Effects of melatonin in age-related macular degeneration","volume":"1057","author":"Yi","year":"2005","journal-title":"Ann. N. Y Acad. Sci."},{"key":"ref_99","first-page":"1640","article-title":"Effects of melatonin and its receptor antagonist on retinal pigment epithelial cells against hydrogen peroxide damage","volume":"18","author":"Rosen","year":"2012","journal-title":"Mol. Vis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"101507","DOI":"10.1016\/j.arr.2021.101507","article-title":"Stress and telomere shortening: Insights from cellular mechanisms","volume":"73","author":"Lin","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0361-9230(03)00072-8","article-title":"Possible therapy for age-related macular degeneration using human telomerase","volume":"62","author":"Glickman","year":"2004","journal-title":"Brain Res. Bull."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mehy.2010.08.036","article-title":"Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity","volume":"76","author":"Rastmanesh","year":"2011","journal-title":"Med. Hypotheses"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Tisi, A., Feligioni, M., Passacantando, M., Ciancaglini, M., and Maccarone, R. (2021). The Impact of Oxidative Stress on Blood-Retinal Barrier Physiology in Age-Related Macular Degeneration. Cells, 10.","DOI":"10.3390\/cells10010064"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e12643","DOI":"10.1111\/jpi.12643","article-title":"Melatonin protects the retina from experimental nonexudative age-related macular degeneration in mice","volume":"68","author":"Aranda","year":"2020","journal-title":"J. Pineal Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/14728222.2020.1737015","article-title":"Mitochondrial dysfunction in age-related macular degeneration: Melatonin as a potential treatment","volume":"24","author":"Mehrzadi","year":"2020","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Ku, L.C., Sheu, M.L., Cheng, H.H., Lee, C.Y., Tsai, Y.C., Tsai, C.Y., Lin, K.H., Lai, L.C., and Lai, D.W. (2023). Melatonin protects retinal integrity through mediated immune homeostasis in the sodium iodate-induced mouse model of age-related macular degeneration. Biomed. Pharmacother., 161.","DOI":"10.1016\/j.biopha.2023.114476"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00018-022-04412-0","article-title":"Melatonin relieves hepatic lipid dysmetabolism caused by aging via modifying the secondary bile acid pattern of gut microbes","volume":"79","author":"Wei","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jcmgh.2021.06.024","article-title":"The Mechanism of Oral Melatonin Ameliorates Intestinal and Adipose Lipid Dysmetabolism Through Reducing Escherichia Coli-Derived Lipopolysaccharide","volume":"12","author":"Rong","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e00002-20","DOI":"10.1128\/mSystems.00002-20","article-title":"Administration of Exogenous Melatonin Improves the Diurnal Rhythms of the Gut Microbiota in Mice Fed a High-Fat Diet","volume":"5","author":"Yin","year":"2020","journal-title":"mSystems"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2174\/1871530319666191009161228","article-title":"Dietary Melatonin Protects Against Behavioural, Metabolic, Oxidative, and Organ Morphological Changes in Mice that are Fed High-Fat, High- Sugar Diet","volume":"20","author":"Onaolapo","year":"2020","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e12524","DOI":"10.1111\/jpi.12524","article-title":"Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high-fat diet-fed mice","volume":"65","author":"Yin","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4239\/wjd.v9.i7.99","article-title":"Circadian dysrhythmia-linked diabetes mellitus: Examining melatonin\u2019s roles in prophylaxis and management","volume":"9","author":"Onaolapo","year":"2018","journal-title":"World J. Diabetes"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/eye.2014.127","article-title":"Melatonin prevents retinal oxidative stress and vascular changes in diabetic rats","volume":"28","author":"Ozdemir","year":"2014","journal-title":"Eye"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jpi.12008","article-title":"Therapeutic efficacy of melatonin in reducing retinal damage in an experimental model of early type 2 diabetes in rats","volume":"54","author":"Salido","year":"2013","journal-title":"J. Pineal Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3528274","DOI":"10.1155\/2016\/3528274","article-title":"Protective Effects of Melatonin on Retinal Inflammation and Oxidative Stress in Experimental Diabetic Retinopathy","volume":"2016","author":"Jiang","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/fcp.12361","article-title":"Protective effect of melatonin in the diabetic rat retina","volume":"32","author":"Mehrzadi","year":"2018","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"8463125","DOI":"10.1155\/2019\/8463125","article-title":"Melatonin Affects Mitochondrial Fission\/Fusion Dynamics in the Diabetic Retina","volume":"2019","author":"Chang","year":"2019","journal-title":"J. Diabetes Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejphar.2018.06.011","article-title":"Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin\/nicotinamide induced pre-diabetes","volume":"833","author":"Djordjevic","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1002\/jcp.29716","article-title":"Melatonin inhibits M\u00fcller cell activation and pro-inflammatory cytokine production via upregulating the MEG3\/miR-204\/Sirt1 axis in experimental diabetic retinopathy","volume":"235","author":"Tu","year":"2020","journal-title":"J. Cell Physiol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Tu, Y., Song, E., Wang, Z., Ji, N., Zhu, L., Wang, K., Sun, H., Zhang, Y., Zhu, Q., and Liu, X. (2021). Melatonin attenuates oxidative stress and inflammation of M\u00fcller cells in diabetic retinopathy via activating the Sirt1 pathway. Biomed. Pharmacother., 137.","DOI":"10.1016\/j.biopha.2021.111274"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1002\/jcp.30269","article-title":"Melatonin maintains inner blood-retinal barrier via inhibition of p38\/TXNIP\/NF-\u03baB pathway in diabetic retinopathy","volume":"236","author":"Tang","year":"2021","journal-title":"J. Cell Physiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"108521","DOI":"10.1016\/j.exer.2021.108521","article-title":"Melatonin exerts protective effects on diabetic retinopathy via inhibition of Wnt\/\u03b2-catenin pathway as revealed by quantitative proteomics","volume":"205","author":"Yan","year":"2021","journal-title":"Exp. Eye Res."},{"key":"ref_123","first-page":"10","article-title":"Cellular and Molecular Mechanisms of Retinal Ganglion Cell Death in Hypoxic-Ischemic Injuries","volume":"1","author":"Kaur","year":"2015","journal-title":"J. Neurol. Exp. Neurosci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4068\/cmj.2012.48.2.116","article-title":"The effect of melatonin on retinal ganglion cell survival in ischemic retina","volume":"48","author":"Park","year":"2012","journal-title":"Chonnam Med. J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e12473","DOI":"10.1111\/jpi.12473","article-title":"Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1\u03b1-VEGF pathway in oxygen-induced retinopathy mice","volume":"64","author":"Xu","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Osipova, N.A., Panova, A.Y., Efremov, A.M., Lozinskaya, N.A., Beznos, O.V., and Katargina, L.A. (2024). Melatonin and its bioisosteres as potential therapeutic agents for the treatment of retinopathy of prematurity. Chem. Biol. Drug Des., 103.","DOI":"10.1111\/cbdd.14504"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Miranda-Riestra, A., Estrada-Reyes, R., Torres-Sanchez, E.D., Carre\u00f1o-Garc\u00eda, S., Ortiz, G.G., and Ben\u00edtez-King, G. (2022). Melatonin: A Neurotrophic Factor?. Molecules, 10.","DOI":"10.3390\/molecules27227742"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e12716","DOI":"10.1111\/jpi.12716","article-title":"Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia","volume":"71","author":"Huang","year":"2021","journal-title":"J. Pineal Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/path.2195","article-title":"Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: The beneficial effect of melatonin administration","volume":"212","author":"Kaur","year":"2007","journal-title":"J. Pathol."},{"key":"ref_130","first-page":"8080564","article-title":"Effects of Selenium and Melatonin on Ocular Ischemic Syndrome","volume":"6","author":"Telek","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuro.2005.06.002","article-title":"Neurochemical Evidence to Implicate Elevated Glutamate in the Mechanisms of High Intraocular Pressure (IOP)-induced Retinal Ganglion Cell Death in Rat","volume":"26","author":"Nucci","year":"2005","journal-title":"NeuroToxicology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: A review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration","volume":"130","author":"Investigators","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e2651645","DOI":"10.1155\/2017\/2651645","article-title":"Long-Term Clinical Course of Normal-Tension Glaucoma: 20 Years of Experience","volume":"2017","author":"Jin","year":"2017","journal-title":"J. Ophthalmol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200522010-00001","article-title":"Management of Glaucoma: Focus on Pharmacological Therapy","volume":"22","author":"Marquis","year":"2005","journal-title":"Drugs Aging"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.2010.00816.x","article-title":"The role of melatonin in glaucoma: Implications concerning pathophysiological relevance and therapeutic potential","volume":"50","author":"Agorastos","year":"2011","journal-title":"J. Pineal Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1111\/aos.13253","article-title":"Elevated intraocular pressure increases melatonin levels in the aqueous humour","volume":"95","author":"Alkozi","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-\u00c1guila, A., Mart\u00edn-Gil, A., Carpena-Torres, C., Pastrana, C., and Carracedo, G. (2021). Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma. Biomolecules, 11.","DOI":"10.3390\/biom11030340"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mce.2012.01.004","article-title":"Melatonin membrane receptors in peripheral tissues: Distribution and functions","volume":"351","author":"Slominski","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e12430","DOI":"10.1111\/jpi.12430","article-title":"The role and therapeutic potential of melatonin in age-related ocular diseases","volume":"63","author":"Crooke","year":"2017","journal-title":"J. Pineal Res."},{"key":"ref_143","first-page":"530","article-title":"Changes in melatonin receptor expression in a murine model of glaucoma","volume":"26","author":"Fonseca","year":"2020","journal-title":"Mol. Vis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2011.02.056","article-title":"Removal of Melatonin Receptor Type 1 Increases Intraocular Pressure and Retinal Ganglion Cells Death in the Mouse","volume":"494","author":"Baba","year":"2011","journal-title":"Neurosci. Lett."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/IJG.0b013e3182934bb4","article-title":"Is the melatonin receptor type 1 involved in the pathogenesis of glaucoma?","volume":"22","author":"Tosini","year":"2013","journal-title":"J. Glaucoma"},{"key":"ref_146","first-page":"1337","article-title":"Melatonin concentrations in serum of primary glaucoma patients","volume":"11","author":"Ma","year":"2018","journal-title":"Int. J. Ophthalmol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/IJG.0000000000001130","article-title":"Melatonin Levels in Patients with Primary Open-angle Glaucoma with High or Low Intraocular Pressure","volume":"28","author":"Kim","year":"2019","journal-title":"J. Glaucoma"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e12662","DOI":"10.1111\/jpi.12662","article-title":"Decreased melatonin secretion in patients with glaucoma: Quantitative association with glaucoma severity in the LIGHT study","volume":"69","author":"Yoshikawa","year":"2020","journal-title":"J. Pineal Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/07420528.2019.1566741","article-title":"Progressive retinal ganglion cell loss in primary open-angle glaucoma is associated with temperature circadian rhythm phase delay and compromised sleep","volume":"36","author":"Gubin","year":"2019","journal-title":"Chronobiol. Int."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.110.178319","article-title":"Design of Novel Melatonin Analogs for the Reduction of Intraocular Pressure in Normotensive Rabbits","volume":"337","author":"Huete","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.115.231456","article-title":"Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice","volume":"357","author":"Fonseca","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00061198-199708000-00010","article-title":"Brimonidine: A new alpha2-adrenoreceptor agonist for glaucoma treatment","volume":"6","author":"Greenfield","year":"1997","journal-title":"J. Glaucoma"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2019.01.012","article-title":"Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma","volume":"297","author":"Davis","year":"2019","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1213\/ane.0b013e3181907ebe","article-title":"Melatonin Provides Anxiolysis, Enhances Analgesia, Decreases Intraocular Pressure, and Promotes Better Operating Conditions During Cataract Surgery Under Topical Anesthesia","volume":"108","author":"Ismail","year":"2009","journal-title":"Anesth. Analg."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/opo.12189","article-title":"Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients","volume":"35","author":"Pescosolido","year":"2015","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2012.12.009","article-title":"Melatonin analogue agomelatine reduces rabbit\u2019s intraocular pressure in normotensive and hypertensive conditions","volume":"701","author":"Fonseca","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5214\/ans.0972.7531.2008.150101","article-title":"Melatonin Offers Protection against Glutamate Receptor Agonists in Neuronal Cultures","volume":"15","author":"Southgate","year":"2010","journal-title":"Ann. Neurosci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1034\/j.1600-079X.2001.280203.x","article-title":"Neuroprotection by melatonin from glutamate-induced excitotoxicity during development of the cerebellum in the chick embryo","volume":"28","author":"Espinar","year":"2000","journal-title":"J. Pineal Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.lfs.2018.12.053","article-title":"Protective role of melatonin on retinal ganglionar cell: In vitro an in vivo evidences","volume":"218","author":"Fajreldines","year":"2019","journal-title":"Life Sci."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e1628","DOI":"10.1002\/wsbm.1628","article-title":"Secondary glaucoma: Toward interventions based on molecular underpinnings","volume":"16","author":"Mueller","year":"2024","journal-title":"WIREs Mech. Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e12916","DOI":"10.1111\/jpi.12916","article-title":"Melatonin prevents EAAC1 deletion-induced retinal ganglion cell degeneration by inhibiting apoptosis and senescence","volume":"76","author":"Hu","year":"2024","journal-title":"J. Pineal Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ICU.0b013e3280895aea","article-title":"Glaucoma as a neurodegenerative disease","volume":"18","author":"Gupta","year":"2007","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_163","first-page":"4320408","article-title":"Neuroprotection in Glaucoma: Old and New Promising Treatments","volume":"2017","author":"Rusciano","year":"2017","journal-title":"Adv. Pharmacol. Sci."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"623725","DOI":"10.3389\/fimmu.2021.623725","article-title":"Uveitis: Molecular Pathogenesis and Emerging Therapies","volume":"12","author":"Egwuagu","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2174\/1570159X15666170113122120","article-title":"Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases","volume":"15","author":"Aranda","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1111\/bph.12873","article-title":"Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation","volume":"171","author":"Sande","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"164","DOI":"10.18097\/PBMC20166202164","article-title":"Effect of melatonin instillations on the clinical course of experimental uveitis and biochemical processes in tears and aqueous humor","volume":"62","author":"Chesnokova","year":"2016","journal-title":"Biomed. Khim"},{"key":"ref_168","first-page":"321","article-title":"Stezenie melatoniny w surowicy chorych ze zwyrodnieniem barwnikowym siatk\u00f3wki [Levels of melatonin in serum of patients with retinitis pigmentosa]","volume":"97","author":"Buntner","year":"1995","journal-title":"Klin. Oczna"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e12428","DOI":"10.1111\/jpi.12428","article-title":"Melatonin delays photoreceptor degeneration in a mouse model of autosomal recessive retinitis pigmentosa","volume":"63","author":"Xu","year":"2017","journal-title":"J. Pineal Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00001756-200104170-00029","article-title":"Melatonin delays photoreceptor degeneration in the rds\/rds mouse","volume":"12","author":"Liang","year":"2001","journal-title":"Neuroreport"},{"key":"ref_171","first-page":"e9196","article-title":"Short-Wavelength Light-Blocking Filters and Oral Melatonin Administration in Patients with Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial","volume":"124","author":"Sobas","year":"2023","journal-title":"JMIR Res. Protoc."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1444-0938.2003.tb03123.x","article-title":"The biological basis of myopic refractive error","volume":"86","author":"Morgan","year":"2003","journal-title":"Clin. Exp. Optom."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0197-0186(95)00050-I","article-title":"Melatonin and deprivation myopia in chickens","volume":"28","author":"Hoffmann","year":"1996","journal-title":"Neurochem. Int."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Spaide, R., Ohno-Matsui, K., and Yannuzzi, L. (2014). Pathologic Myopia, Springer.","DOI":"10.1007\/978-1-4614-8338-0"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/opo.12396","article-title":"Myopes have significantly higher serum melatonin concentrations than non-myopes","volume":"37","author":"Kearney","year":"2017","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/02713683.2021.1894580","article-title":"Myopia, Melatonin and Conjunctival Ultraviolet Autofluorescence: A Comparative Cross-sectional Study in Indian Myopes","volume":"46","author":"Kumar","year":"2021","journal-title":"Curr. Eye Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"7961623","DOI":"10.1155\/2023\/7961623","article-title":"A Cross-Sectional Study of Myopia and Morning Melatonin Status in Northern Irish Adolescent Children","volume":"2023","author":"Fulton","year":"2023","journal-title":"J. Ophthalmol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"zsad265","DOI":"10.1093\/sleep\/zsad265","article-title":"Delayed melatonin circadian timing, lower melatonin output, and sleep disruptions in myopic, or short-sighted, children","volume":"47","author":"Chakraborty","year":"2024","journal-title":"Sleep."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/opo.13214","article-title":"Associations between systemic melatonin and human myopia: A systematic review","volume":"43","author":"Hussain","year":"2023","journal-title":"Ophthalmic Physiol. Opt."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/4\/441\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:20:47Z","timestamp":1760106047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/4\/441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":179,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["ph17040441"],"URL":"https:\/\/doi.org\/10.3390\/ph17040441","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]}}}